2026 Growth Recovery/Expansion is Here: Long-term accomplished founder and management have shepherded SBC from a solo clinic in 2000 to a dominant global cosmetic treatment center franchiser and cash generation machine with little debt. H1:26 has already demonstrated post-2025 revenue growth recovery, which we expect to continue. However, it is the impact of AI efforts in H2:26 that could turn recovery into strong growth. Accordingly, the Company should likely begin to grow anew going forward with additional prospects, global and Japanese M&A targets, and AI as well as Longevity initiatives. Steps have also been taken over the last several months to increase free float, as management remains confident in their operating strategy.
